Access cutting-edge migraine treatment through this clinical trial at a research site in Brooklyn. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Brooklyn location
Preparing your pre-screening questions…
Access migraine specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related migraine treatment provided free
Check if you qualify for this migraine clinical trial in Brooklyn, NY
No-Cost Study Care
Local to Brooklyn
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Rimegepant (Nurtec) is an orally administered small molecule CGRP receptor antagonist with efficacy in the acute treatment of migraine. Rizatriptan benzoate (MAXALT), is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist. Rizatriptan binds with high affinity to human cloned 5-HT1B and 5-HT1D receptors which leads to activation of these receptors results in cranial vessel constriction, inhibition of neuropeptide release and reduced transmission in trigeminal pain pathways with resultant relieve of the headache. Teh investigators hypothesize that the administration of Rimegepant ODT would provide better analgesic efficacy than Rizatriptan ODT with respect to analgesic efficacy at 60 min and 120 minutes in ED patients with acute headache. This is a prospective, randomized, double-blind superiority trial evaluating and comparing analgesic efficacy and safety of Rimegepant ODT 75 mg to Rizatriptan ODT 10 mg in adult patients presenting to the Emergency Department of Maimonides Medical Center with acute migraine headache.
Sponsor: Antonios Likourezos
Yes, this clinical trial (NCT06473597) has an active research site in Brooklyn, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for migraine treatment options in Brooklyn, NY, this clinical trial (NCT06473597) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Brooklyn research site is actively enrolling participants for this clinical trial. You'll receive care from experienced migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all migraine clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Brooklyn — not just this study.
Browse Heart Attack Trials in Brooklyn →